Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.

This is the latest of a series of reviews focused on the analysis of genotoxic impurities. This review summarises the analytical approaches reported in the literature relating to hydrazine, hydrazines, hydrazides and hydrazones. It is intended to provide guidance for analysts needing to develop procedures to control such impurities, particularly where this is due to concerns relating to their potential genotoxicity. Of particular note is the wide variety of techniques employed, both chromatographic and spectroscopic, with most involving derivatisation. Such a wide variety of options allow the analyst a real choice in terms of selecting the most appropriate technique specific to their requirements. Several generic methodologies, covering the three main analytical approaches; i.e. HPLC (high performance liquid chromatography), GC (gas chromatography) and IC (ion chromatography), are also described.

[1]  N. Cauchon,et al.  Hydrophilic interaction liquid chromatography with alcohol as a weak eluent. , 2009, Journal of chromatography. A.

[2]  R. S. Chaudhary,et al.  High-performance thin-layer chromatographic method for monitoring degradation products of rifampicin in drug excipient interaction studies , 1994 .

[3]  D. F. Bain,et al.  Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatographic assay. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  B. Glickman,et al.  Mutational specificities of environmental carcinogens in the lacl gene of Escherichia coli H. V: DNA sequence analysis of mutations in bacteria recovered from the liver of swiss mice exposed to 1,2‐dimethylhydrazine, azoxymethane, and methylazoxymethanolacetate , 1991, Molecular carcinogenesis.

[5]  A. Chakraborti,et al.  LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. , 2007, Journal of pharmaceutical and biomedical analysis.

[6]  E. Wang,et al.  Detection of hydrazine, methylhydrazine, and isoniazid by capillary electrophoresis with a palladium-modified microdisk array electrode. , 1996, Analytical chemistry.

[7]  L. Capitán-Vallvey,et al.  Solid-phase spectrophotometric determination of trace amounts of hydrazine at sub-ng ml−1 level , 1997 .

[8]  David Q. Liu,et al.  A generic approach for the determination of trace hydrazine in drug substances using in situ derivatization-headspace GC-MS. , 2009, Journal of pharmaceutical and biomedical analysis.

[9]  C. L. Narayana,et al.  A validated LC method for the quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugs. , 2000, Journal of pharmaceutical and biomedical analysis.

[10]  A. Viksna,et al.  Application of hydrophilic interaction chromatography for simultaneous separation of six impurities of mildronate substance. , 2008, Journal of pharmaceutical and biomedical analysis.

[11]  J. Vessman,et al.  Determination of hydrazine in hydralazine by capillary gas chromatography with nitrogen-selective detection after benzaldehyde derivatization. , 1990, Journal of Chromatography A.

[12]  I. Schmeltz,et al.  Chemical studies on tobacco smoke. Quantitative analysis of hydrazine in tobacco and cigarette smoke. , 1974, Analytical chemistry.

[13]  D. Elder,et al.  Analytical approaches for the detection of epoxides and hydroperoxides in active pharmaceutical ingredients, drug products and herbals. , 2010, Journal of pharmaceutical and biomedical analysis.

[14]  A Carlin,et al.  Stability of isoniazid in isoniazid syrup: formation of hydrazine. , 1998, Journal of pharmaceutical and biomedical analysis.

[15]  E. G. Lovering,et al.  Determination of hydrazine in pharmaceuticals IV: Hydrazine and benzylhydrazine in isocarboxazid. , 1985, Journal of pharmaceutical sciences.

[16]  D. Elder,et al.  Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[17]  J. Klimeš,et al.  HPLC-DAD and MS/MS analysis of novel drug candidates from the group of aromatic hydrazones revealing the presence of geometric isomers. , 2008, Journal of pharmaceutical and biomedical analysis.

[18]  Saranjit Singh,et al.  Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin. , 2003, Journal of pharmaceutical and biomedical analysis.

[19]  D. Elder,et al.  Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[20]  R. W. Sears,et al.  High-performance liquid chromatographic determination of isoniazid and 1-isonicotinyl-2-lactosylhydrazine in isoniazid tablet formulations. , 1980, Journal of pharmaceutical sciences.

[21]  E. G. Lovering,et al.  Determination of hydrazine in pharmaceuticals III: hydralazine and isoniazid using GLC. , 1983, Journal of pharmaceutical sciences.

[22]  N. Jagota,et al.  Determination of trace levels of hydrazine in the penultimate intermediate of a novel anti-infective agent. , 1998, Journal of pharmaceutical and biomedical analysis.

[23]  S. De Flora,et al.  DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. , 1981, Cancer research.

[24]  Y. Kumar,et al.  Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor. , 2004, Journal of pharmaceutical and biomedical analysis.

[25]  L. Niu,et al.  Detection of hydrazine, methylhydrazine and isoniazid by capillary electrophoresis with a 4-pyridyl hydroquinone self-assembled microdisk platinum electrode. , 1999, Journal of pharmaceutical and biomedical analysis.

[26]  J. Klimeš,et al.  HPLC study on stability of pyridoxal isonicotinoyl hydrazone. , 2006, Journal of pharmaceutical and biomedical analysis.

[27]  K. Altria,et al.  Quantitative microemulsion electrokinetic capillary chromatography analysis of formulated drug products , 2001 .

[28]  M. Srinivasu,et al.  Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC. , 2002, Journal of pharmaceutical and biomedical analysis.

[29]  T. Matsushima,et al.  Relationships between chemical structures and mutagenicity: a preliminary survey for a database of mutagenicity test results of new work place chemicals. , 2001, Industrial health.

[30]  G. Font,et al.  Fluorimetric determination of hydrazine in isoniazid formulations with 2-hydroxy-1-naphthaldehyde. , 1988, Journal of pharmaceutical and biomedical analysis.

[31]  A. G. Davidson Assay of hydrazine in isoniazid and its formulations by difference spectrophotometry. , 1982, The Analyst.

[32]  P. Madhavan,et al.  Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate. , 2006, Journal of pharmaceutical and biomedical analysis.

[33]  M. B. Devani,et al.  Spectrophotometric determination of isoniazid in presence of its hydrazones. , 1978, Journal of pharmaceutical sciences.

[34]  Bernard Testa,et al.  Drug Metabolism: Chemical and Biochemical Aspects , 1976 .

[35]  D. C. Zhao,et al.  Interactions between drug substances and excipients. 1. Fluorescence and HPLC studies of triazolophthalazine derivatives from hydralazine hydrochloride and starch. , 1996, Journal of pharmaceutical sciences.